Community/Retail

Traditionally, the World's Fair artistic exhibitions have incorporated elements from current scientific evolution. For example, families applied industrial science and the scientific method to everyday life in the early 20th century, so modern art emphasized reductionism in an ever more complicated world.

The FDA has granted Orphan Drug Designation to Boehringer Ingelheim's nintedanib for the treatment of systemic sclerosis (SSc), also known as scleroderma, including associated interstitial lung disease (SSc-ILD).

Meperidine was synthetically derived in 1939 as an anticholinergic agent, but was discovered to possess analgesic properties shortly after.

New study results show broad-spectrum antibiotic use within 2 years of life increases type 1 diabetes (T1D) risk in Caesarean-delivered children.

Contact lens-related keratitis is on the rise, according to a recent CDC report.

It's completely normal to not want to be blamed for something, and it's also completely normal to blame others.

Rite Aid has announced that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 440 pharmacies in Kentucky, Ohio, Oregon, and Vermont without a prescription.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacy associations work in collaboration.

National Association of Specialty Pharmacy President Burt Zweigenhaft has announced the industry's two much-anticipated awards recognizing the best in the business of specialty pharmacy this year.

The FDA recently approved Aralez Pharmaceuticals' Yosprala, a once-daily, fixed-dose combination of the antiplatelet agent aspirin and the proton pump inhibitor omeprazole.

Price Chopper and Market 32 customers and teammates from throughout the company's six state footprint helped raise $23,679 during the month-long fundraising campaign for United Way.

Wholesalers, Grocers, Regional Chains and State Pharmacist Groups Back Legislation

Is there a place for pharmacists to assume a prescribing role?

If you've ever worked in a community pharmacy, you know it's a very hectic setting.

Biosimilars have become increasingly popular in the last few years.

Recently, there's been an uptick in studies and articles about functional dyspepsia (FD). The reason is probably that FD is quite common (10% to 15% of the US population has it), and many clinicians fail to differentiate FD from other gastrointestinal disturbances.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), describes how pharmacy school curriculums have changed.

No. 1 Print and Online Source for Pharmacists Takes to Social Media to #ThankAPharmacist

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses collaborations with the AACP.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacies can become sites for student rotations.

Teva has just launched daptomycin for injection, a generic version of Cubicin, in the US market.

Nearly 300 Attendees Received Flu Shots and Health Screenings

Medicines for Europe and GPhA are committed to supporting positive developments of the negotiations for a TTIP and in particular the regulatory cooperation of pharmaceuticals therein.

In case you missed it...

The American Academy of Pediatrics (AAP) is now advising against giving codeine to children.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how practicing pharmacists can become preceptors.

Virtus Pharmaceuticals Opco II is recalling 7 batches of hyoscyamine sulfate 0.125 mg, which include tablet, sublingual, and orally disintegrating tablet forms, due to superpotent and subpotent test results.